$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • G01N-033/54
  • G01N-033/68
  • G01N-027/26
출원번호 US-0261217 (1981-04-20)
우선권정보 CA-0348033 (1980-03-20)
국제출원번호 PCT/EP80/00018 (1980-03-18)
§371/§102 date 19810420 (19810420)
국제공개번호 WO-8102790 (1981-10-01)
발명자 / 주소
  • Gordon Julian (Arlesheim CHX) Staehelin Theophil (Arlesheim CHX) Towbin Harry (Allschwil CHX)
출원인 / 주소
  • Ciba-Geigy Corporation (Ardsley NY 02)
인용정보 피인용 횟수 : 94  인용 특허 : 0

초록

Solid supports for proteins consisting of nitrocellulose sheets containing a replica of an electropherogram of proteins as obtained by electrophoretic separation in a gel. Faithful replica of such electropherograms on the nitrocellulose support can be obtained by contacting the gel with a nitrocellu

대표청구항

A solid support for proteins consisting of a porous nitrocellulose sheet containing a replica of an electropherogram of proteins in a gel wherein the replica is obtained by electrophoretic transfer of said electropherogram from the gel. A process for obtaining a solid support for protein consisting

이 특허를 인용한 특허 (94)

  1. Kok Lim Jiu,SGX, Analytical apparatus and method for automated blot assay.
  2. Paul James Davis GB; Michael Evans Prior GB; Keith May GB, Analytical test device for imuno assays and methods of using same.
  3. Chandler Howard M.,CAX, Assay device.
  4. Aoki Kei Roger ; Spanoyannis Athena F., Assay for detecting the presence of botulinum toxin neutralizing antibodies in a patient serum sample.
  5. Davis,Paul James; Prior,Michael Evans; May,Keith, Assays.
  6. Davis,Paul James; Prior,Michael Evans; May,Keith, Assays.
  7. Davis,Paul James; Prior,Michael Evans; May,Keith, Assays.
  8. May Keith (Bedfordshire GB2) Prior Michael E. (Northamptonshire GB2) Richards Ian (Bedford GB2), Assays.
  9. May,Keith; Prior,Michael Evans; Richards,Ian, Assays.
  10. Spinale, Francis G.; Zile, Michael R.; Stroud, Robert E., Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids.
  11. Aoki Kei Roger ; Spanoyannis Athena Faye, Botulinum toxin antibody detection assay.
  12. Bohannon,Robert; Chapman,Glen; Morris,Alan; Scholz Steele,Maria; Green,Martin; Hartzog,Phillip; Adeneye,Oluyomi, Bulking materials containing starch reagent for use in test devices.
  13. May Keith,GBX ; Prior Michael Evans,GBX ; Richards Ian,GBX, Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents.
  14. May Keith,GBX ; Prior Michael Evans,GBX ; Richards Ian,GBX, Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents.
  15. May, Keith; Prior, Michael Evans; Richards, Ian, Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents.
  16. Neurath A. Robert (New York NY), Composition for use in immunoassays.
  17. Bermudes, David Gordon, Compositions and methods for determining successful immunization by one or more vaccines.
  18. Dhillon, Ammen P.; Lee, Amy C. H.; MacLachlan, Ian, Compositions and methods for silencing SMAD4.
  19. Santamaria, Pedro, Compositions and methods for the prevention and treatment of cancer.
  20. Santamaria, Pedro, Compositions and methods for the prevention and treatment of cancer.
  21. Schneewind, Olaf; Cheng, Alice; Missiakas, Dominique M.; Kim, Hwan Keun, Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response.
  22. Schneewind, Olaf; Cheng, Alice; Missiakas, Dominique M.; Kim, Hwan Keun, Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response.
  23. Schneewind, Olaf; Cheng, Alice; Missiakas, Dominique M.; Kim, Hwan Keun, Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response.
  24. Cheever, Martin A.; Disis, Mary L., Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.
  25. Cheever, Martin A; Disis, Mary L, Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.
  26. Cheever, Martin A; Disis, Mary L, Compounds for eliciting or enhancing immune reactivity to HER-2/protein for prevention or treatment of malignancies in which the HER-2/oncogene is associated.
  27. Spinale, Francis G.; Stroud, Robert E.; Zile, Michael R., Detecting diastolic heart failure by protease and protease inhibitor plasma profiling.
  28. Van Aken Morgan (Bainbridge Island WA) Paskell Stefan L. (Bainbridge Island WA), Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases.
  29. Van Aken Morgan (Bainbridge Island WA) Paskell Stefan L. (Bainbridge Island WA), Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases.
  30. Margalit, Ilana; Yogev, Uri; Sela, Itay; Katz, Yuri; Sartiel, Adam, Electro-blotting devices, systems, and kits and methods for their use.
  31. Margalit, Ilana; Yogev, Uri; Sela, Itay; Katz, Yuri; Sartiel, Adam, Electro-blotting devices, systems, and kits and methods for their use.
  32. Margalit, Ilana; Yogev, Uri; Sela, Itay; Katz, Yuri; Sartiel, Adam; Updyke, Timothy, Electro-blotting devices, systems, and kits and methods for their use.
  33. Margalit, Ilana; Yogev, Uri; Sela, Itay; Katz, Yuri; Sartiel, Adam, Electro-blotting devices, systems, and kits, and methods for their use.
  34. Margalit, Ilana; Yogev, Uri; Sela, Itay; Katz, Yuri; Sartiel, Adam, Electro-blotting devices, systems, and kits, and methods for their use.
  35. Kilmer, Gregory John; Wolf, Brian David; Starwalt, Scott Eugene; Judd, Gary G; Webb, Brian Lynn, Electroblot transfer buffer.
  36. Kilmer, Gregory John; Wolf, Brian David; Starwalt, Scott Eugene; Judd, Gary G; Webb, Brian Lynn, Electroblot transfer buffer.
  37. Benarieh, Ronen; Lifshitz, Raviv, Electroblotting apparatus.
  38. Benarieh, Ronen; Lifshitz, Raviv, Electroblotting apparatus.
  39. Benarieh, Ronen; Lifshitz, Raviv, Electroblotting apparatus.
  40. Littlehales William J. (Point Richmond CA), Electroblotting technique for transferring specimens from a polyacrylamide electrophoresis or like gel onto a membrane.
  41. Arvedson, Tara; Dyas, Gregory; Rottman, James B.; Sasu, Barbra; Bi, Xiao-juan; Lee, Grace Ki Jeong; Sheng, Jackie Z., Ferroportin antibodies and methods of use.
  42. Arvedson, Tara; Dyas, Gregory; Rottman, James B.; Sasu, Barbra; Bi, Xiao-juan; Lee, Grace Ki Jeong; Sheng, Jackie Z., Ferroportin antibodies and methods of use.
  43. Sastry, K. Jagannadha; Arlinghaus, Ralph B.; Nehete, Pramod N., HIV-specific T-cell induction.
  44. Sastry,K. Jagannadha; Arlinghaus,Ralph B.; Nehete,Pramod N., HIV-specific T-cell induction.
  45. Sasu, Barbra; Haniu, Mitsuru; Boone, Thomas Charles; Bi, Xiao-juan; Lee, Grace Ki Jeong; Arvedson, Tara; Winters, Aaron George; Cooke, Keegan; Sheng, Jackie Z., Hepcidin, hepcidin antagonists and methods of use.
  46. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is a.
  47. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is a.
  48. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated.
  49. Cheever, Martin A.; Disis, Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated.
  50. Cheever,Martin A; Disis,Mary L, Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated.
  51. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated.
  52. Cheever, Martin A; Disis, Mary L, Immune reactivity to HER-2/protein for diagnosis and treatment of malignancies in which the HER-2/oncogene is associated.
  53. Nagai Keiichi (Tokyo JPX) Tokinaga Daizo (Hachioji JPX) Imai Kazumichi (Kodaira JPX) Yasuda Kenji (Tokyo JPX) Takahashi Satoshi (Kokubunji JPX) Kobayashi Teruaki (Hachioji JPX), Immunoassay for measuring the concentration of antigen in a sample.
  54. Tokinaga Daizo (Hachioji JPX) Kobayashi Teruaki (Hachioji JPX) Imai Kazumichi (Kokubunji JPX), Immunoassay method.
  55. Marks Janet M. (Coronado CA), Immunoassay method for detection of antibodies and antigens.
  56. Chandler Howard M. ; Piasio Roger N. ; Prouty Karen, Immunochromatographic assay device.
  57. Francoeur Ann-Michele (San Diego CA), Individual-specific antibody identification methods.
  58. Blatt Joel M. ; Allen Michael P. ; Patel Paul J., Method and device producing a predetermined distribution of detectable change in assays.
  59. Osther Kurt B. (Dallas TX), Method for detection of antibodies to HTLV-III and diagnostic test kit useful therewith.
  60. Lehmann,Werner, Method for producing an array for detecting constituents from a biological sample.
  61. Osther Kurt B. (Dallas TX) Dyll Louis M. (Rockwall TX), Method for rapid and sensitive detection of HIV-1 antibodies.
  62. Ching Shanfun (Libertyville IL) Billings Patricia A. (Gurnee IL) Gordon Julian (Lake Bluff IL), Method for storing labile proteins.
  63. Roth, Mark, Method of diagnosing autoimmune disease.
  64. Santamaria, Pedro, Methods and compositions for sustained immunotherapy.
  65. Santamaria, Pedro, Methods and compositions for treating multiple sclerosis and related disorders.
  66. Santamaria, Pedro, Methods and compositions for treating multiple sclerosis and related disorders.
  67. Shayman, James A.; Abe, Akira; Hiraoka, Miki, Methods and compositions for using aleveolar macrophage phospholipase A2.
  68. Shayman,James A.; Abe,Akira; Hiraoka,Miki, Methods and compositions for using alveolar macrophage phospholipase A2.
  69. Schneewind, Olaf; Cheng, Alice G.; Missiakas, Dominique M.; Kim, Hwan Keun, Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides.
  70. Olson, Eric N.; Lu, Jianrong; McKinsey, Timothy, Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression.
  71. Olson,Eric N.; Lu,Jianrong; McKinsey,Timothy, Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression.
  72. Cheever Martin A. ; Disis Mary L., Methods for eliciting or enhancing reactivity to HER-2/neu protein.
  73. Francoeur Ann-Michele (San Diego CA), Methods of identification employing antibody profiles.
  74. Park, Dongsu; Spencer, David; Lapteva, Natalia, Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods.
  75. Chandler Howard M.,CAX, Multiple component chromatographic assay device.
  76. Bohannon,Robert; Chapman,Glen; Morris,Alan; Scholz Steele,Maria; Green,Martin; Hartzog,Phillip; Adeneye,Oluyomi, Non-sugar sweeteners for use in test devices.
  77. Chandler Howard M.,CAX, Opposable-element assay devices, kits, and methods employing them.
  78. Mandecki Wlodek (Vernon Hills IL) Hayden Mark A. (Vernon Hills IL), Polycationic buffers and method for gel electrophoresis of nucleic acids.
  79. Niman Henry L. (Pittsburgh PA), Polypeptide-induced monoclonal receptors to protein ligands.
  80. Mukherjee, Rupak; Gold, Michael R.; Spinale, Francis G., Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling.
  81. Spinale, Francis G.; Stroud, Robert E.; Zile, Michael R., Predicting heart failure following myocardial infarction by protease and protease inhibitor profiling.
  82. Ohnishi, Michihiro, Probe for detecting substance in body and system for detecting substance in body making use of the probe.
  83. Ching, Shanfun; Billing, Patricia A.; Gordon, Julian, Process for immunochromatography with colloidal particles.
  84. Campos-Gonzalez, Roberto; Hume, Steven Darrell, Rapid protein identification using antibody mixtures.
  85. Bernstein David ; Childs Mary Ann ; Trainor William ; Wier Majorie ; Gray Erick, Rapid self-contained assay format.
  86. Levin Andrew E. (Cambridge MA), Templet for simultaneous screening of several antibodies and method of using the same.
  87. Arntzen, Charles J.; Blake, Mary E.; Gutterman, Jordan U., Triterpene compositions and methods for use thereof.
  88. Arntzen, Charles J.; Blake, Mary E.; Gutterman, Jordan U.; Hoffmann, Joseph J.; Jayatilake, Gamini S.; Bailey, David T., Triterpene compositions and methods for use thereof.
  89. Arntzen, Charles J.; Blake, Mary E.; Gutterman, Jordan U.; Hoffmann, Joseph J.; Jayatilake, Gamini S.; Bailey, David T., Triterpene compositions and methods for use thereof.
  90. Arntzen, Charles J.; Gutterman, Jordan U., Triterpene compositions and methods for use thereof.
  91. Arntzen,Charles J.; Blake,Mary E.; Gutterman,Jordan U., Triterpene compositions and methods for use thereof.
  92. Charles J. Arntzen ; Mary E. Blake ; Jordan U. Gutterman ; Joseph J. Hoffmann ; Gamini S. Jayatilake ; David T. Bailey, Triterpene compositions and methods for use thereof.
  93. Haridas, Valsala; Gutterman, Jordan U., Triterpene compositions and methods for use thereof.
  94. Haridas, Valsala; Gutterman, Jordan U., Triterpene compositions and methods for use thereof.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로